{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:48:09Z","timestamp":1793724489689,"version":"4.6.1"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971166"],"award-info":[{"award-number":["31971166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Given the abundant stroma of the liver and that cirrhosis or hepatic fibrosis is the premalignant condition of most hepatocellular carcinomas (HCC), underscores the critical interaction between extracellular matrix (ECM) stiffness and the tumor microenvironment (TME) in the initiation, progression, and immunotherapy of HCC. This review presents a comprehensive exploration of the factors that regulate matrix stiffness, including the activation of cancer-associated fibroblasts (CAFs), the excessive deposition of ECM proteins, and cross-linking. Furthermore, this review explores the underlying molecular pathways through which matrix stiffness affects the prevalence of tumors and immune cells. Based on these premises, we delve into the potential targets and roles of pharmacological interventions targeting matrix stiffness in HCC and its immunotherapy, and highlight the considerable potential of biomaterials for the development of ECM stiffness-targeted agents. The potential exists for such agents to enhance the efficacy of immunotherapy and prolong the survival of patients diagnosed with HCC.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1773909","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:41:14Z","timestamp":1773124874000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Extracellular matrix stiffness in hepatocellular carcinoma: mechanisms and targeted therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhuolin","family":"Zhou","sequence":"first","affiliation":[{"name":"Cancer Center, Wuhan University Renmin Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[{"name":"Cancer Center, Wuhan University Renmin Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet commission on addressing the global hepatocellular carcinoma burden: Comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1470-2045(22)00326-6","article-title":"Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): A multicentre, open-label, randomised, phase 3 trial","volume":"23","author":"Kelley","year":"2022","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.37500","article-title":"Matrix mechanics as regulatory factors and therapeutic targets in hepatic fibrosis","volume":"15","author":"Chen","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24108","article-title":"Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells","volume":"53","author":"Schrader","year":"2011","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: New findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0039-3399502","article-title":"Mechanotransduction in liver diseases","volume":"40","author":"Kang","year":"2020","journal-title":"Semin Liver Dis"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30969","article-title":"Is the total amount as important as localization and type of collagen in liver fibrosis attributable to steatohepatitis","volume":"71","author":"Karsdal","year":"2020","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202560","article-title":"In situ regulation and mechanisms of 3D matrix stiffness on the activation and reversion of hepatic stellate cells","volume":"12","author":"Chen","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09684-z","article-title":"Exosomes derived from hepatitis B virus-infected hepatocytes promote liver fibrosis via miR-222\/TFRC axis","volume":"39","author":"Zhang","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136777","article-title":"Liver disease: Induction, progression, immunological mechanisms, and therapeutic interventions","volume":"22","author":"Neshat","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA(+) myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41419-022-04802-z","article-title":"MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"G234","DOI":"10.1152\/ajpgi.00254.2021","article-title":"Stiffness is associated with hepatic stellate cell heterogeneity during liver fibrosis","volume":"322","author":"Kostallari","year":"2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325065","article-title":"Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGF\u03b2 signalling","volume":"71","author":"Hung","year":"2022","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-022-01252-0","article-title":"Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy","volume":"15","author":"Jiang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1053\/j.gastro.2018.02.015","article-title":"P300 acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts","volume":"154","author":"Dou","year":"2018","journal-title":"Gastroenterology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1074\/jbc.M115.691519","article-title":"Molecular mechanism responsible for fibronectin-controlled alterations in matrix stiffness in advanced chronic liver fibrogenesis","volume":"291","author":"Iwasaki","year":"2016","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.matbio.2017.08.004","article-title":"Decorin and biglycan are necessary for maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons","volume":"64","author":"Robinson","year":"2017","journal-title":"Matrix Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081902","article-title":"Proteoglycans in cancer: Friends or enemies? A special focus on hepatocellular carcinoma","volume":"14","author":"Dituri","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"C289","DOI":"10.1152\/ajpcell.00039.2022","article-title":"Syndecan-1 in liver pathophysiology","volume":"323","author":"Reszegi","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"C651","DOI":"10.1152\/ajpcell.00215.2022","article-title":"Proteolysis: A key post-translational modification regulating proteoglycans","volume":"323","author":"Mead","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"B27","article-title":"Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B virus-related chronic hepatitis and liver fibrosis\/cirrhosis","volume":"39","author":"Ai","year":"2024","journal-title":"Histol Histopathol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2211947120","article-title":"Mechanoepigenetic regulation of extracellular matrix homeostasis via Yap and Taz","volume":"120","author":"Jones","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The Hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.03.005","article-title":"Agrin to YAP in cancer and neuromuscular junctions","volume":"3","author":"Xiong","year":"2017","journal-title":"Trends Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2019.12.002","article-title":"Agrin mediates angiogenesis in the tumor microenvironment","volume":"6","author":"Chakraborty","year":"2020","journal-title":"Trends Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102286","article-title":"Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion","volume":"52","author":"Hieu","year":"2022","journal-title":"Redox Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203315","article-title":"Scar-degrading endothelial cells as a treatment for advanced liver fibrosis","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119407","article-title":"Matrix stiffness regulates SMC functions via TGF-\u03b2 signaling pathway","volume":"221","author":"Tian","year":"2019","journal-title":"Biomaterials"},{"key":"B35","doi-asserted-by":"publisher","first-page":"111768","DOI":"10.1016\/j.jep.2019.01.045","article-title":"Raw and vinegar processed Curcuma wenyujin regulates hepatic fibrosis via bloking TGF-\u03b2\/Smad signaling pathways and up-regulation of MMP-2\/TIMP-1 ratio","volume":"246","author":"Xie","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32777","article-title":"Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease","volume":"77","author":"Leung","year":"2023","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"crossref","first-page":"114632","DOI":"10.1016\/j.biopha.2023.114632","article-title":"Corrigendum to: \"Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis\", [Biomed. Pharmacother. 161; (2023): 114472","volume":"162","author":"Shan","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167205","article-title":"Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes collagen cross-linking and ECM stiffening to induce liver fibrosis","volume":"1870","author":"Yue","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.neo.2021.05.014","article-title":"Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas","volume":"23","author":"Sato","year":"2021","journal-title":"Neoplasia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-023-01727-9","article-title":"Lysyl hydroxylase LH1 promotes confined migration and metastasis of cancer cells by stabilizing Septin2 to enhance actin network","volume":"22","author":"Yang","year":"2023","journal-title":"Mol Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-15-0307","article-title":"Cancer-associated fibroblasts induce a collagen cross-link switch in tumor stroma","volume":"14","author":"Pankova","year":"2016","journal-title":"Mol Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31236","article-title":"Lysyl oxidase (LOX) family members: Rationale and their potential as therapeutic targets for liver fibrosis","volume":"72","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911378","article-title":"Lysyl oxidases: Orchestrators of cellular behavior and ECM remodeling and homeostasis","volume":"23","author":"Zaffryar-Eilot","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14010","article-title":"Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma","volume":"110","author":"Umezaki","year":"2019","journal-title":"Cancer Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0948-8","article-title":"Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis","volume":"18","author":"Li","year":"2019","journal-title":"Mol Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5009\/gnl17569","article-title":"Increased expression of the matrix-modifying enzyme lysyl oxidase-like 2 in aggressive hepatocellular carcinoma with poor prognosis","volume":"13","author":"Choi","year":"2019","journal-title":"Gut Liver"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA117.001601","article-title":"Periostin promotes liver fibrogenesis by activating lysyl oxidase in hepatic stellate cells","volume":"293","author":"Kumar","year":"2018","journal-title":"J Biol Chem"},{"key":"B48","article-title":"Boosting collagen deposition with a lysyl oxidase\/bone morphogenetic protein-1 cocktail","volume":"156","author":"Rosell-Garc\u00eda","year":"2020","journal-title":"Methods Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.01.019","article-title":"Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking","volume":"1864","author":"Zhao","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1183808","article-title":"Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis","volume":"10","author":"Zhao","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13322","article-title":"Increased matrix stiffness promotes tumor progression of residual hepatocellular carcinoma after insufficient heat treatment","volume":"108","author":"Zhang","year":"2017","journal-title":"Cancer Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7150\/thno.44789","article-title":"CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12967-025-06325-5","article-title":"CAFs activated by YAP1 upregulate cancer matrix stiffness to mediate hepatocellular carcinoma progression","volume":"23","author":"Yan","year":"2025","journal-title":"J Transl Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31792","article-title":"Cancer-associated fibroblast-mediated cellular crosstalk supports hepatocellular carcinoma progression","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1172\/JCI146987","article-title":"Tumor restriction by type I collagen opposes tumor-promoting effects of cancer-associated fibroblasts","volume":"131","author":"Bhattacharjee","year":"2021","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","first-page":"6996","DOI":"10.1002\/jcp.26491","article-title":"Effect of substrate stiffness on hepatocyte migration and cellular Young's modulus","volume":"233","author":"Xia","year":"2018","journal-title":"J Cell Physiol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv Drug Delivery Rev"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.031","article-title":"TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis","volume":"76","author":"Wang","year":"2022","journal-title":"J Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000319","article-title":"Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-\u03b2\/SMAD signaling","volume":"78","author":"Song","year":"2023","journal-title":"Hepatology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/polym12091903","article-title":"The effect of matrix stiffness on human hepatocyte migration and function-an in vitro research","volume":"12","author":"Xia","year":"2020","journal-title":"Polymers (Basel)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8515","article-title":"Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells","volume":"7","author":"You","year":"2016","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112831","article-title":"A soft matrix enhances the cancer stem cell phenotype of HCC cells","volume":"20","author":"Tian","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202002483","article-title":"Chemotherapy-enriched THBS2-deficient cancer stem cells drive hepatocarcinogenesis through matrix softness induced histone H3 modifications","volume":"8","author":"Ng","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14259","article-title":"Liver stiffness correlates with serum osteopontin and TAZ expression in human liver cirrhosis","volume":"1465","author":"Khajehahmadi","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1159\/000525081","article-title":"Predictive value of liver stiffness measurement by magnetic resonance elastography for complications after liver resection: a systematic review and meta-analysis","volume":"103","author":"Liang","year":"2022","journal-title":"Digestion"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1186\/s12885-024-12973-5","article-title":"Matrix stiffness-related extracellular matrix signatures and the DYNLL1 protein promote hepatocellular carcinoma progression through the Wnt\/\u03b2-catenin pathway","volume":"24","author":"Shen","year":"2024","journal-title":"BMC Cancer"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216832","article-title":"USP40 promotes hepatocellular carcinoma progression through a YAP\/USP40 positive feedback loop","volume":"589","author":"Mo","year":"2024","journal-title":"Cancer Lett"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01784-9","article-title":"Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression","volume":"127","author":"Zhao","year":"2022","journal-title":"Br J Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-023-01092-1","article-title":"Stiff matrix induces exosome secretion to promote tumour growth","volume":"25","author":"Wu","year":"2023","journal-title":"Nat Cell Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/s41419-021-04418-9","article-title":"Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates Malignant progression","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105367118","article-title":"Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche","volume":"118","author":"Hupfer","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B75","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41580-022-00530-6","article-title":"Mechanisms and roles of podosomes and invadopodia","volume":"24","author":"Linder","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216597","article-title":"A synergistic regulation works in matrix stiffness-driven invadopodia formation in HCC","volume":"582","author":"Zhang","year":"2024","journal-title":"Cancer Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13045-019-0795-5","article-title":"Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis","volume":"12","author":"Dong","year":"2019","journal-title":"J Hematol Oncol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12364","article-title":"Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma","volume":"42","author":"Li","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"B79","article-title":"Integrin \u03b1V\u03b25\/Akt\/Sp1 pathway participates in matrix stiffness-mediated effects on VEGFR2 upregulation in vascular endothelial cells","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13046-018-0761-z","article-title":"Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation","volume":"37","author":"Wu","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejca.2021.01.011","article-title":"The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism","volume":"147","author":"Wu","year":"2021","journal-title":"Eur J Cancer"},{"key":"B82","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-023-05550-4","article-title":"Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.07.006","article-title":"Beyond matrix stiffness: targeting force-induced cancer drug resistance","volume":"9","author":"Kalli","year":"2023","journal-title":"Trends Cancer"},{"key":"B84","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/s12967-022-03778-w","article-title":"Heterogeneous matrix stiffness regulates the cancer stem-like cell phenotype in hepatocellular carcinoma","volume":"20","author":"Wei","year":"2022","journal-title":"J Transl Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.08.021","article-title":"Matrix stiffness-dependent PD-L2 deficiency improves SMYD3\/xCT-mediated ferroptosis and the efficacy of anti-PD-1 in HCC","volume":"73","author":"Wang","year":"2025","journal-title":"J Adv Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12935-022-02634-7","article-title":"Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma","volume":"22","author":"Wang","year":"2022","journal-title":"Cancer Cell Int"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/bab.1302","article-title":"Role of three-dimensional matrix stiffness in regulating the chemoresistance of hepatocellular carcinoma cells","volume":"62","author":"Liu","year":"2015","journal-title":"Biotechnol Appl Biochem"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.662135","article-title":"Tumor microenvironment alters chemoresistance of hepatocellular carcinoma through CYP3A4 metabolic activity","volume":"11","author":"\u00d6zkan","year":"2021","journal-title":"Front Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13872","article-title":"Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes","volume":"38","author":"Tseng","year":"2018","journal-title":"Liver Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/mc.22718","article-title":"Metformin in combination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo","volume":"57","author":"Zhang","year":"2018","journal-title":"Mol Carcinog"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116966","article-title":"Metformin attenuates hepatoma cell proliferation by decreasing glycolytic flux through the HIF-1\u03b1\/PFKFB3\/PFK1 pathway","volume":"239","author":"Hu","year":"2019","journal-title":"Life Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081231","article-title":"Metformin and cancer glucose metabolism: at the bench or at the bedside","volume":"11","author":"Marini","year":"2021","journal-title":"Biomolecules"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01563","article-title":"Matrix stiffness-upregulated microRNA-17-5p attenuates the intervention effects of metformin on HCC invasion and metastasis by targeting the PTEN\/PI3K\/Akt pathway","volume":"10","author":"Gao","year":"2020","journal-title":"Front Oncol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020490","article-title":"Stiffer matrix accelerates migration of hepatocellular carcinoma cells through enhanced aerobic glycolysis via the MAPK-YAP signaling","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.03.015","article-title":"An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming","volume":"30","author":"Liu","year":"2022","journal-title":"Mol Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.82177","article-title":"Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP\/TEAD4\/ACADL axis in hepatocellular carcinoma","volume":"19","author":"Cai","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev"},{"key":"B100","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ccell.2020.05.005","article-title":"Reduction of liver metastasis stiffness improves response to bevacizumab in metastatic colorectal cancer","volume":"37","author":"Shen","year":"2020","journal-title":"Cancer Cell"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.74","article-title":"Mechanical forces in the immune system","volume":"17","author":"Huse","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00761-w","article-title":"Tuning immunity through tissue mechanotransduction","volume":"23","author":"Du","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58688.sa2","article-title":"Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment","volume":"10","author":"Nicolas-Boluda","year":"2021","journal-title":"Elife"},{"key":"B104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41698-018-0068-8","article-title":"Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology","volume":"2","author":"Okrah","year":"2018","journal-title":"NPJ Precis Oncol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.0c16478","article-title":"A hydrogel-integrated culture device to interrogate T cell activation with physicochemical cues","volume":"12","author":"Chin","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2011.12.011","article-title":"Mechanosensing in T lymphocyte activation","volume":"102","author":"Judokusumo","year":"2012","journal-title":"Biophys J"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120797","article-title":"Biphasic response of T cell activation to substrate stiffness","volume":"273","author":"Yuan","year":"2021","journal-title":"Biomaterials"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55185","article-title":"The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy","volume":"9","author":"Lim","year":"2020","journal-title":"Elife"},{"key":"B109","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41467-021-23482-5","article-title":"Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing","volume":"12","author":"Atcha","year":"2021","journal-title":"Nat Commun"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg5859","article-title":"Piezo1 channels restrain regulatory T cells but are dispensable for effector CD4(+) T cell responses","volume":"7","author":"Jairaman","year":"2021","journal-title":"Sci Adv"},{"key":"B111","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79957","article-title":"Dendritic cell Piezo1 directs the differentiation of T(H)1 and T(reg) cells in cancer","volume":"11","author":"Wang","year":"2022","journal-title":"Elife"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.37702","article-title":"Improving regulatory T cell production through mechanosensing","volume":"112","author":"Shi","year":"2024","journal-title":"J BioMed Mater Res A"},{"key":"B113","doi-asserted-by":"publisher","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat Commun"},{"key":"B114","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41568-023-00560-y","article-title":"Dynamics and specificities of T cells in cancer immunotherapy","volume":"23","author":"Oliveira","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/S0016-5085(18)31043-6","article-title":"Association between expression level of PD1 by tumor-infiltrating CD8(+) T cells and features of hepatocellular carcinoma","volume":"155","author":"Kim","year":"2018","journal-title":"Gastroenterology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.actbio.2022.08.005","article-title":"The role of matrix stiffness in cancer stromal cell fate and targeting therapeutic strategies","volume":"150","author":"Wei","year":"2022","journal-title":"Acta Biomater"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1494250","article-title":"The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategies","volume":"15","author":"Ma","year":"2024","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.7150\/thno.86103","article-title":"Piezo1 specific deletion in macrophage protects the progression of liver fibrosis in mice","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj3289","article-title":"Stiffness sensing via Piezo1 enhances macrophage efferocytosis and promotes the resolution of liver fibrosis","volume":"10","author":"Wang","year":"2024","journal-title":"Sci Adv"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2020.05.004","article-title":"Substrate stiffness modulates bone marrow-derived macrophage polarization through NF-\u03baB signaling pathway","volume":"5","author":"Chen","year":"2020","journal-title":"Bioact Mater"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15566","article-title":"Matrix stiffness-mediated effects on macrophages polarization and their LOXL2 expression","volume":"288","author":"Xing","year":"2021","journal-title":"FEBS J"},{"key":"B123","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1038\/s41467-023-42187-5","article-title":"SUN1\/2 controls macrophage polarization via modulating nuclear size and stiffness","volume":"14","author":"Jiao","year":"2023","journal-title":"Nat Commun"},{"key":"B124","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1021\/acsbiomaterials.0c00669","article-title":"Biomimetic matrix stiffness modulates hepatocellular carcinoma Malignant phenotypes and macrophage polarization through multiple modes of mechanical feedbacks","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Biomater Sci Eng"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-023-01173-w","article-title":"Macrophages serve as bidirectional regulators and potential therapeutic targets for liver fibrosis","volume":"81","author":"Liang","year":"2023","journal-title":"Cell Biochem Biophys"},{"key":"B126","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/s41467-024-46357-x","article-title":"ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice","volume":"15","author":"Zhuang","year":"2024","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s42003-025-07735-3","article-title":"EZH2-mediated macrophage-to-myofibroblast transition contributes to calcium oxalate crystal-induced kidney fibrosis","volume":"8","author":"Xia","year":"2025","journal-title":"Commun Biol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.136629","article-title":"Exosomal miRNA reprogramming in pyroptotic macrophage drives silica-induced fibroblast-to-myofibroblast transition and pulmonary fibrosis","volume":"483","author":"Zhang","year":"2025","journal-title":"J Hazard Mater"},{"key":"B129","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s40001-023-01488-7","article-title":"Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis","volume":"28","author":"Xia","year":"2023","journal-title":"Eur J Med Res"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016050573","article-title":"Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury","volume":"28","author":"Wang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101235","article-title":"Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition","volume":"9","author":"Tang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302203","article-title":"Hematopoietic transcription factor RUNX1 is essential for promoting macrophage-myofibroblast transition in non-small-cell lung carcinoma","volume":"11","author":"Tang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"B133","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41423-020-00568-6","article-title":"Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease","volume":"18","author":"Horst","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1913","article-title":"Single MHC-I expression promotes virus-induced liver immunopathology","volume":"6","author":"Xu","year":"2022","journal-title":"Hepatol Commun"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2100656","article-title":"Microfluidic squeezing enables MHC class I antigen presentation by diverse immune cells to elicit CD8(+) T cell responses with antitumor activity","volume":"208","author":"Booty","year":"2022","journal-title":"J Immunol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152507","article-title":"Maintaining proteostasis under mechanical stress","volume":"22","author":"H\u00f6hfeld","year":"2021","journal-title":"EMBO Rep"},{"key":"B137","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajpath.2019.09.019","article-title":"The major histocompatibility complex class II-CD4 immunologic synapse in alcoholic hepatitis and autoimmune liver pathology: The role of aberrant major histocompatibility complex class II in hepatocytes","volume":"190","author":"Lu","year":"2020","journal-title":"Am J Pathol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.814155","article-title":"Impact of antigen presentation mechanisms on immune response in autoimmune hepatitis","volume":"12","author":"Fasano","year":"2021","journal-title":"Front Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113213","article-title":"Mechanotransduction in response to ECM stiffening impairs cGAS immune signaling in tumor cells","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep"},{"key":"B140","doi-asserted-by":"publisher","first-page":"17511","DOI":"10.1038\/s41598-017-17787-z","article-title":"Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells","volume":"7","author":"Mennens","year":"2017","journal-title":"Sci Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123362","article-title":"Dendritic cell migration is tuned by mechanical stiffness of the confining space","volume":"10","author":"Choi","year":"2021","journal-title":"Cells"},{"key":"B142","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","article-title":"Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma","volume":"184","author":"Sun","year":"2021","journal-title":"Cell"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746436","article-title":"Dysfunctional immune regulation in autoimmune hepatitis: From pathogenesis to novel therapies","volume":"12","author":"Vuerich","year":"2021","journal-title":"Front Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.05.002","article-title":"MHC II(-), but not MHC II(+), hepatic stellate cells contribute to liver fibrosis of mice in infection with Schistosoma japonicum","volume":"1863","author":"Zhou","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114448","article-title":"Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer","volume":"188","author":"Li","year":"2022","journal-title":"Adv Drug Delivery Rev"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2023.06.002","article-title":"Collagen architecture and signaling orchestrate cancer development","volume":"9","author":"Su","year":"2023","journal-title":"Trends Cancer"},{"key":"B147","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s12967-022-03759-z","article-title":"Targeting HSP47 and HSP70: Promising therapeutic approaches in liver fibrosis management","volume":"20","author":"Abd El-Fattah","year":"2022","journal-title":"J Transl Med"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1515\/hsz-2017-0177","article-title":"Heat shock protein 47 effects on hepatic stellate cell-associated receptors in hepatic fibrosis of Schistosoma japonicum-infected mice","volume":"398","author":"Zhao","year":"2017","journal-title":"Biol Chem"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15477","article-title":"Biglycan promotes hepatic fibrosis through activating heat shock protein 47","volume":"43","author":"Yu","year":"2023","journal-title":"Liver Int"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat Biotechnol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111535","article-title":"MiR-29b regulates TGF-\u03b21-induced epithelial-mesenchymal transition by inhibiting heat shock protein 47 expression in airway epithelial cells","volume":"22","author":"Shin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B152","doi-asserted-by":"publisher","first-page":"15563","DOI":"10.1038\/s41598-019-52064-1","article-title":"TGF-\u03b21-induced HSP47 regulates extracellular matrix accumulation via Smad2\/3 signaling pathways in nasal fibroblasts","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.07.085","article-title":"Small molecule inhibitor of HSP47 prevents pro-fibrotic mechanisms of fibroblasts in vitro","volume":"530","author":"Miyamura","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-020-10069-3","article-title":"Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study","volume":"14","author":"Poo","year":"2020","journal-title":"Hepatol Int"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2024.00472","article-title":"Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B: Protocol for a phase 3 randomized trial","volume":"13","author":"Cai","year":"2025","journal-title":"J Clin Transl Hepatol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111360","article-title":"Hepatocarcinogenesis prevention by pirfenidone is PPAR\u03b3 mediated and involves modification of nuclear NF-kB p65\/p50 ratio","volume":"22","author":"Silva-Gomez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/cells13121013","article-title":"Pirfenidone reverts global DNA hypomethylation, promoting DNMT1\/UHRF\/PCNA coupling complex in experimental hepatocarcinoma","volume":"13","author":"Miranda-Roblero","year":"2024","journal-title":"Cells"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14113","article-title":"Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma","volume":"39","author":"Faivre","year":"2019","journal-title":"Liver Int"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2018.01.006","article-title":"Lysyl oxidase in cancer inhibition and metastasis","volume":"417","author":"Johnston","year":"2018","journal-title":"Cancer Lett"},{"key":"B160","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12951-023-01942-y","article-title":"Mesenchymal stem cell-derived exosomal miR-27b-3p alleviates liver fibrosis via downregulating YAP\/LOXL2 pathway","volume":"21","author":"Cheng","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0068","article-title":"Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- \u03baB signaling pathways","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-268425","article-title":"Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice","volume":"30","author":"Liu","year":"2016","journal-title":"FASEB J"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4705","article-title":"Lysyl oxidase assists tumor-initiating cells to enhance angiogenesis in hepatocellular carcinoma","volume":"54","author":"Yang","year":"2019","journal-title":"Int J Oncol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13014-024-02513-7","article-title":"Evaluating ECM stiffness and liver cancer radiation response via shear-wave elasticity in 3D culture models","volume":"19","author":"Lu","year":"2024","journal-title":"Radiat Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14074","article-title":"The lysyl oxidase like 2\/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis","volume":"23","author":"Schilter","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00614-y","article-title":"A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer","volume":"4","author":"Chitty","year":"2023","journal-title":"Nat Cancer"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-014-0142-1","article-title":"The copper chelator tetrathiomolybdate regressed bleomycin-induced pulmonary fibrosis in mice, by reducing lysyl oxidase expressions","volume":"162","author":"Ovet","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1177\/11795549231204612","article-title":"The antitumor impact of combining hepatic artery ligation with copper chelators for liver cancer","volume":"17","author":"Zeng","year":"2023","journal-title":"Clin Med Insights Oncol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.2174\/1871520622666220907115027","article-title":"Multitargeting strategy using tetrathiomolybdate and lenvatinib: Maximizing antiangiogenesis activity in a preclinical liver cancer model","volume":"23","author":"Nan","year":"2023","journal-title":"Anti-Cancer Agents Med Chem"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw9886","article-title":"Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice","volume":"366","author":"Moya","year":"2019","journal-title":"Science"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32000","article-title":"YAP\/TAZ suppress drug penetration into hepatocellular carcinoma through stromal activation","volume":"74","author":"Cho","year":"2021","journal-title":"Hepatology"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2023.113486","article-title":"YAP1 suppression inhibits autophagy and improves the efficacy of anti-PD-1 immunotherapy in hepatocellular carcinoma","volume":"424","author":"Gao","year":"2023","journal-title":"Exp Cell Res"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7695","article-title":"Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy","volume":"37","author":"Peng","year":"2023","journal-title":"Phytother Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153913","article-title":"Dihydroartemisinin reduced lipid droplet deposition by YAP1 to promote the anti-PD-1 effect in hepatocellular carcinoma","volume":"96","author":"Hao","year":"2022","journal-title":"Phytomedicine"},{"key":"B176","doi-asserted-by":"publisher","first-page":"352ra108","DOI":"10.1126\/scitranslmed.aaf2304","article-title":"Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration","volume":"8","author":"Fan","year":"2016","journal-title":"Sci Transl Med"},{"key":"B177","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41419-025-07745-3","article-title":"TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma","volume":"16","author":"He","year":"2025","journal-title":"Cell Death Dis"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-021-00595-z","article-title":"YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin","volume":"44","author":"Sun","year":"2021","journal-title":"Cell Oncol (Dordr)"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15628","article-title":"Nuclear translocation of YAP drives BMI-associated hepatocarcinogenesis in hepatitis B virus infection","volume":"43","author":"Luo","year":"2023","journal-title":"Liver Int"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.2174\/0113892002351556250123105344","article-title":"In vitro and in vivo drug metabolism analysis of BPI-460372 - a covalent TEAD1\/3\/4 inhibitor","volume":"25","author":"Liu","year":"2024","journal-title":"Curr Drug Metab"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00754-9","article-title":"Direct and selective pharmacological disruption of the YAP\u2013TEAD interface by IAG933 inhibits Hippo-dependent and RAS\u2013MAPK-altered cancers","volume":"5","author":"Chapeau","year":"2024","journal-title":"Nat Cancer"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67312.sa2","article-title":"YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation","volume":"10","author":"He","year":"2021","journal-title":"Elife"},{"key":"B183","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13045-020-00885-3","article-title":"Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy","volume":"13","author":"Li","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01530","article-title":"Structure-based discovery of SD-36 as a potent, selective, and efficacious PROTAC degrader of STAT3 protein","volume":"62","author":"Zhou","year":"2019","journal-title":"J Med Chem"},{"key":"B185","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01223","article-title":"Discovery of novel PROTAC SIRT6 degraders with potent efficacy against hepatocellular carcinoma","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108458","article-title":"Integrins in cancer: Emerging mechanisms and therapeutic opportunities","volume":"247","author":"Liu","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.324","article-title":"Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK\/PI3K\/AKT signaling","volume":"7","author":"Zhang","year":"2016","journal-title":"Cell Death Dis"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1002\/path.5756","article-title":"Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation","volume":"255","author":"Xiao","year":"2021","journal-title":"J Pathol"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2018.06.007","article-title":"Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats","volume":"652","author":"Metwaly","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.7150\/jca.26740","article-title":"Antimetastatic effect of fucoidan-Sargassum against liver cancer cell invadopodia formation via targeting integrin \u03b1V\u03b23 and mediating \u03b1V\u03b23\/Src\/E2F1 signaling","volume":"10","author":"Pan","year":"2019","journal-title":"J Cancer"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113670","article-title":"Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents","volume":"223","author":"Tan","year":"2021","journal-title":"Eur J Med Chem"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.820446","article-title":"A FAK inhibitor boosts anti-PD1 immunotherapy in a hepatocellular carcinoma mouse model","volume":"12","author":"Wei","year":"2021","journal-title":"Front Pharmacol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13046-022-02401-6","article-title":"Targeting TROY-mediated P85a\/AKT\/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma","volume":"41","author":"Liu","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-018-3622-8","article-title":"Phase I study of the anti-\u03b15\u03b21 monoclonal antibody MINT1526A with or without bevacizumab in patients with advanced solid tumors","volume":"82","author":"Weekes","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868809","article-title":"Hepatic tumor stiffness measured by shear wave elastography is prognostic for HCC progression following treatment with anti-PD-1 antibodies plus lenvatinib: A retrospective analysis of two independent cohorts","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol"},{"key":"B197","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40164-024-00476-9","article-title":"Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma","volume":"13","author":"Shen","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J Hepatol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-331342","article-title":"Targeting MMP9 in CTNNB1 mutant hepatocellular carcinoma restores CD8(+) T cell-mediated antitumour immunity and improves anti-PD-1 efficacy","volume":"73","author":"Cai","year":"2024","journal-title":"Gut"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-023-01335-w","article-title":"A phase Ib\/II study of BLU-554, a fibroblast growth factor receptor 4 inhibitor in combination with CS1001, an anti-PD-L1, in patients with locally advanced or metastatic hepatocellular carcinoma","volume":"41","author":"Zhou","year":"2023","journal-title":"Invest New Drugs"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol Res"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910923","article-title":"Immune-mediated ECM depletion improves tumour perfusion and payload delivery","volume":"11","author":"Yeow","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030724","article-title":"Therapeutic strategies to overcome fibrotic barriers to nanomedicine in the pancreatic tumor microenvironment","volume":"15","author":"Tanaka","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.stem.2022.08.012","article-title":"Vaccination-based immunotherapy to target profibrotic cells in liver and lung","volume":"29","author":"Sobecki","year":"2022","journal-title":"Cell Stem Cell"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2023.02.029","article-title":"Nanodrug removes physical barrier to promote T-cell infiltration for enhanced cancer immunotherapy","volume":"356","author":"Xiao","year":"2023","journal-title":"J Control Release"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.7150\/thno.114892","article-title":"Nanodelivery of Y-27632 by RGD-modified liposome enhances radioimmunotherapy of hepatocellular carcinoma via tumor microenvironment matrix stiffness reprogramming","volume":"15","author":"Shen","year":"2025","journal-title":"Theranostics"},{"key":"B209","article-title":"A polymeric extracellular matrix nanoremodeler for activatable cancer photo-immunotherapy","volume":"62","author":"Zhang","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.0c00417","article-title":"Photothermal depletion of cancer-associated fibroblasts normalizes tumor stiffness in desmoplastic cholangiocarcinoma","volume":"14","author":"Nicol\u00e1s-Boluda","year":"2020","journal-title":"ACS Nano"},{"key":"B211","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12951-024-02399-3","article-title":"Self-delivery photothermal-boosted-nanobike multi-overcoming immune escape by photothermal\/chemical\/immune synergistic therapy against HCC","volume":"22","author":"Yang","year":"2024","journal-title":"J Nanobiotechnology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T06:41:17Z","timestamp":1773124877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":211,"alternative-id":["10.3389\/fimmu.2026.1773909"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1773909","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1773909"}}